N/A N=30 Randomized Double-blind Prevention

Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP)

Skin Diseases · Surgical Site Infection

Bottom Line

View on ClinicalTrials.gov: NCT02500758 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2017

Primary outcome: Primary: Change in the Release of Skin Flora From the Hands From Baseline to 5 Minutes After Disinfection by Surgical Scrubbing (Time Frame- "Baseline and 5 Minutes"). — 3.96; 3.87 CFU/ml

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Preparatory handwash (Procedure); Preoperative surgical scrubbing using 3% PCMX (Procedure); Preoperative surgical scrubbing using 4% CHG (Procedure)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Ricardo Becerro de Bengoa Vallejo
Primary completion: Jul 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in the Release of Skin Flora From the Hands From Baseline to 5 Minutes After Disinfection by Surgical Scrubbing (Time Frame- "Baseline and 5 Minutes").	3.96; 3.87	—
SECONDARY Change in the Release of Skin Flora From the Hands From Baseline to 3 Hours After Surgical Scrub Disinfection, Wearing Surgical Gloves (Time Frame- "Baseline and 3 Hours").	4.54; 4.65	—

Summary

Despite the wide variety of products and antiseptic agents, no agent is ideal for every situation. The investigators would like to evaluate the difference in reducing bacterial load, using 4% chlorhexidine digluconate and 3% parachlorometaxylenol after a preoperative surgical scrubbing.

Eligibility Criteria

Inclusion Criteria

No systemic diseases.
Healthy skin on hands, without cuts or abrasions.
Short and clean fingernails.
No use of substances with antimicrobial action (e.g. medicated soaps or creams).

Exclusion Criteria

History of eczema.
History of psoriasis.
Allergies to any of the ingredients of the solutions or contraindication to its use.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02500758). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.